Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 11, 2004
Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanomaKristin Andersen, Jahn M Nesland, Ruth Holm, et al.
Data in Brief|November 24, 2015
Construction of a plasmid coding for green fluorescent protein tagged cathepsin L and data on expression in colorectal carcinoma cellsTripti Tamhane, Brit K Wolters, Rukshala Illukkumbura, et al.
Archiv Der Pharmazie|August 16, 2019
Design, synthesis and biological evaluation of 6-substituted quinolines derived from cabozantinib as c-Met inhibitorsVegard Torp Lien, Solveig Pettersen, Mads Haugland Haugen, et al.
International Journal of Cancer|July 10, 2009
Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanomaGeir Frode Oy, Ana Slipicevic, Ben Davidson, et al.
Melanoma Research|March 14, 2008
S100B in bone marrow aspirates in healthy individuals and malignant melanoma patientsRagnar S Faye, Elisabeth Paus, Gunhild M Maelandsmo, et al.
Plos One|January 18, 2013
Nuclear legumain activity in colorectal cancerMads H Haugen, Harald T Johansen, Solveig J Pettersen, et al.
Cancer Gene Therapy|January 29, 2005
PCI-enhanced adenoviral transduction employs the known uptake mechanism of adenoviral particlesBirgit Ø Engesaeter, Anette Bonsted, Kristian Berg, et al.
Plos One|May 28, 2010
Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanomaLina Prasmickaite, Birgit Ø Engesaeter, Nirma Skrbo, et al.
The FEBS Journal|August 18, 2009
Collagen I regulates matrix metalloproteinase-2 activation in osteosarcoma cells independent of S100A4Renate Elenjord, Jasmine B Allen, Harald T Johansen, et al.
Cancer Medicine|June 9, 2016
Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapyKjetil Boye, Havjin Jacob, Kari-Anne M Frikstad, et al.
Pageof 6